全文获取类型
收费全文 | 14405篇 |
免费 | 1484篇 |
国内免费 | 39篇 |
专业分类
耳鼻咽喉 | 155篇 |
儿科学 | 395篇 |
妇产科学 | 397篇 |
基础医学 | 2141篇 |
口腔科学 | 240篇 |
临床医学 | 1592篇 |
内科学 | 2917篇 |
皮肤病学 | 221篇 |
神经病学 | 1291篇 |
特种医学 | 489篇 |
外国民族医学 | 10篇 |
外科学 | 1814篇 |
综合类 | 305篇 |
一般理论 | 8篇 |
预防医学 | 1509篇 |
眼科学 | 287篇 |
药学 | 1017篇 |
中国医学 | 38篇 |
肿瘤学 | 1102篇 |
出版年
2023年 | 122篇 |
2022年 | 93篇 |
2021年 | 392篇 |
2020年 | 253篇 |
2019年 | 377篇 |
2018年 | 424篇 |
2017年 | 314篇 |
2016年 | 274篇 |
2015年 | 374篇 |
2014年 | 434篇 |
2013年 | 620篇 |
2012年 | 899篇 |
2011年 | 929篇 |
2010年 | 516篇 |
2009年 | 462篇 |
2008年 | 771篇 |
2007年 | 731篇 |
2006年 | 717篇 |
2005年 | 682篇 |
2004年 | 618篇 |
2003年 | 557篇 |
2002年 | 542篇 |
2001年 | 316篇 |
2000年 | 307篇 |
1999年 | 273篇 |
1998年 | 134篇 |
1997年 | 89篇 |
1996年 | 106篇 |
1995年 | 112篇 |
1994年 | 91篇 |
1993年 | 78篇 |
1992年 | 224篇 |
1991年 | 197篇 |
1990年 | 167篇 |
1989年 | 166篇 |
1988年 | 167篇 |
1987年 | 167篇 |
1986年 | 180篇 |
1985年 | 175篇 |
1984年 | 107篇 |
1983年 | 114篇 |
1982年 | 76篇 |
1979年 | 125篇 |
1978年 | 100篇 |
1977年 | 72篇 |
1976年 | 99篇 |
1974年 | 102篇 |
1973年 | 120篇 |
1972年 | 87篇 |
1970年 | 73篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
Alicia C. McDonald PhD MPH Jeremy Gernand PhD Nathaniel R. Geyer DrPH Hongke Wu MD MPH Yanxu Yang MPH Ming Wang PhD 《Cancer》2022,128(9):1832-1839
3.
4.
5.
Mariángeles González Fernández Elena Villamañán Inmaculada Jiménez-Nácher Francisco Moreno Chamaida Plasencia Francisco Gayá Alicia Herrero Alejandro Balsa 《Reumatología clinica》2021,17(6):335-342
ObjectiveTo assess the evolution of cost per patient/year and the cost per patient/year/drug in patients with rheumatoid arthritis (RA) receiving biological treatments. To analyze and quantify the factors influencing this evolution, such as the optimization of the biological drugs, the use of biosimilars, and official discounts and discounts obtained after negotiated procedures. In addition, to assess specific clinical parameters of disease activity in these patients.MethodsRetrospective, observational study conducted in a Spanish tertiary hospital. Adult patients diagnosed with RA under treatment from 2009 to 2017 were included.Results320, 270 and 389 patients were included in 2009, 2013 and 2017, respectively. The patient/year cost decreased from 10,789€ in 2009, 7491€ in 2013 to 7116€ in 2017. In 2017, due to the established competition, discounts of 14% and 29.5% were achieved on etanercept and its biosimilar; 11.5%, 17.8%, 17.9%, 17.3% on adalimumab, certolizumab, golimumab and tocilizumab IV respectively, and 24.6% and 43.1% on infliximab and its biosimilar. The percentage of patients optimized in 2017 was 35.2%. The annual saving in 2017 was 1,288,535€ (830,000€ due to dose optimization and/or administration regimens, 249,666€ corresponding to 7.5% of the official discount and 208,868€ after negotiated procedures).ConclusionThe annual cost per patient in RA decreased considerably due to different factors, such as discounts on the purchase of drugs due to official discounts and negotiated procedures, together with the optimization of therapies, the latter being the factor that contributed most to this decrease. 相似文献
6.
7.
Maruyama Jessica Mayumi Santos Iná S. Munhoz Tiago Neuenfeld Matijasevich Alicia 《European child & adolescent psychiatry》2021,30(12):1939-1948
European Child & Adolescent Psychiatry - There is growing evidence that adolescent positive attributes and social aptitudes are associated with beneficial outcomes, including higher educational... 相似文献
8.
E.D.H. Gates J.S. Weinberg S.S. Prabhu J.S. Lin J. Hamilton J.D. Hazle G.N. Fuller V. Baladandayuthapani D.T. Fuentes D. Schellingerhout 《AJNR. American journal of neuroradiology》2021,42(1):102
BACKGROUND AND PURPOSE:Increased cellular density is a hallmark of gliomas, both in the bulk of the tumor and in areas of tumor infiltration into surrounding brain. Altered cellular density causes altered imaging findings, but the degree to which cellular density can be quantitatively estimated from imaging is unknown. The purpose of this study was to discover the best MR imaging and processing techniques to make quantitative and spatially specific estimates of cellular density.MATERIALS AND METHODS:We collected stereotactic biopsies in a prospective imaging clinical trial targeting untreated patients with gliomas at our institution undergoing their first resection. The data included preoperative MR imaging with conventional anatomic, diffusion, perfusion, and permeability sequences and quantitative histopathology on biopsy samples. We then used multiple machine learning methodologies to estimate cellular density using local intensity information from the MR images and quantitative cellular density measurements at the biopsy coordinates as the criterion standard.RESULTS:The random forest methodology estimated cellular density with R2 = 0.59 between predicted and observed values using 4 input imaging sequences chosen from our full set of imaging data (T2, fractional anisotropy, CBF, and area under the curve from permeability imaging). Limiting input to conventional MR images (T1 pre- and postcontrast, T2, and FLAIR) yielded slightly degraded performance (R2 = 0.52). Outputs were also reported as graphic maps.CONCLUSIONS:Cellular density can be estimated with moderate-to-strong correlations using MR imaging inputs. The random forest machine learning model provided the best estimates. These spatially specific estimates of cellular density will likely be useful in guiding both diagnosis and treatment.Increased cellular density (CD) is a hallmark of cancer and a key feature in histologic glioma analysis.1 Mapping cellular density throughout a tumor would be a valuable tool to probe how tumors infiltrate and analyze the transition between diseased and healthy brain. However, measuring CD requires tissue, which entails additional risks and is expensive to obtain. There is no currently accepted clinical algorithm to translate imaging data into quantitative assessments of CD.There is great need for a method to estimate CD noninvasively in human patients with gliomas. In this article, we describe the development of such a method using MR imaging data inputs by correlating with multiple biopsy specimens acquired during a prospective human clinical trial. We obtained comprehensive MR imaging, including conventional, diffusion, perfusion, and permeability imaging sequences. We used machine learning approaches to correlate imaging findings with CD measurements from pathology, devised an algorithm to estimate CD from MR imaging inputs, and generated CD maps for the visual display of the predictions. We identified the most informative imaging data subset. This work has multiple applications in the diagnosis and treatment of patients with gliomas: For example, the method can be used to guide biopsy, resection, and surgery and delineate tumor borderzones both pre- and postoperatively.2 相似文献
9.
10.